Amarin Corp Plc (AMRN)

[everyonesguess]

Christmas is coming and the year is getting the end.

2018 is the KEY-STONE year for AMRN. At 2013 OCT ADCOM, many shareholders were slumped, but kept their hopes alive for 2018 September RI results.

It is a most wonderful September for us. 25% RRR and 20% reduction on CV death are historic. AMRN closed at $2.99 on 9/21 (Friday), then open at$10.44 on Monday 9/24 -- 350% jumped. A few weeks later the PPS breaks $23.

Vascepa is a wonderful CVD drug. It save lives. But not too many patients and Doctors have heard about Vascepa yet. The awareness can be shown by the RX number (say, weekly TRX). According to Sam's data, TRX was 333 in Jan 2013; broke 10K in Jan 2015; broke 20K in Dec 2016, broke 30K in Oct 2018, and now is at 35K. RX numbers will be the best indicator for us. Now, it is still at low levels.

RI results, AHA presentation, sNDA submission, EU marketing, and FDA labeling change all do its jobs to move the RX number to a new level. But the defusing (to patients and doctors) takes time.

AMRN PPS may drop in late Dec, but will be up huge in 2019.

Patience is essential here.

Happy Holidays.